Seizure/Status Epilepticus Flashcards
(46 cards)
Provoked seizures
intoxication
withdrawal (benzo, alcohol)
trauma
meningitis
psychiatric
metabolic derangements
Unprovoked seizures
may or may not need treatment
first time unprovoked does not require medication
Seizure physiology
mismatch of normal inhibitory mechanisms which are responsible for preventing/terminating seizures
GABA (inhibitory)
Glutamate, aspartate, ach (exitatory_
Seizure Epidemiology
most are self limited
30 day mortality of generalized convulsive status epilepticus is 20%
rapid control of seizures fundamental to tx
Status epilepticus definition
old: >30 min
new: > 5 min
Seizure pharm goals
rapid/safe termination of seizure
prevent reoccurence
Avoid CV or respiratory ADRs
Drugs to stop seizure
Benzodiazepines (MLD)
Lorazepam
Diazepam
Midazolam
Drugs to prevent seizure
Phenytoin
Fosphenytoin
levetiracetam
valproic acid
Stage 1 seizure
airway, circulation, lab test, IV thiamine, then dextrose
IV lorazepam or midazolam repeat if needed
0 to 10 min
Stage 2 seizure
Phenytoin or fosphenytoin
Alt:
VPA, phenobarbital, levetiracetam
10 to 30 min
Stage 3 seizure
Midazolam or Propofol
IV infusion
* if intubated = paralyzed, get LTM via EEG
30 min to 90 min
Stage 4 seizure
Pentobarbital
90 min to hours/days
Benzodiazepines first line choice
IV lorazepam 0.1-0.2 mg/kg
(4mg)
Benzodiazepines second line choices
Diazepam IV
0.15mg/kg (5-20mg)
Midazolam IM
0.15-0.20 mg/kg (10mg)
diazepam PR for outpatient
Benzodiazepines ADR
impaired consciousness (20-60%)
Respiratory depression (3-10%)
hypotension (<2%)
Benzodiazepines MOA
bind GABA = increase gaba-ergic transmission
Fos(Phenytoin) MOA
stabilizes neuronal membrane
increase efflux Na
Decrease influx Na
Fos(Phenytoin) Dosing
LD: 20mg/kg (max 50mg/min)
MD: 4-6 mg/kg/day divided 2-3 doses
Fos(Phenytoin) PK
highly protein bound (90%)
uremia increases [free]
Peak [brain] = 6 min after infusion completed
Liver: hydroxylation (primary)
MM kinetics: saturable PK
Fos(Phenytoin) ADR
CV: Na blocker (arrythmia, hypotension, bradycardia, QTc prolongation)
Extravasation (poor IV access)
Rashes/fever/SJS
Neutropenia/ thrombocytopenia
PHENYTOIN mneumonic
PHENYTOIN ADR Mneumonic
P-450
Hirsutism/hypertrichosis
Enlarged gums
Nystagmus
Yellow-browning skin (hepatitis)
Teratogenicity
Osteomalacia (D deficiency)
Interfere folate metabolism (anemia)
Neuropathies (ataxia, headache, vertigo)
Phenytoin CV ADR cause
Incidence correlated to infusion rate
Attributable to diluent: propylene glycol
Fos(Phenytoin) monitoring
Goal 10-20 mcg/dL total
if seizing: higher goal 15-25
level >30 = seizures
Correct for low albumin (<3.5) & CrCL<30
Levetiracetam MOA
binds to SV2A (synaptic vessel protein)
involvement in NT release
NT = neurotransmitter